rfhg_5877.1

Basic information about the TSS

---

TSS ID: rfhg_5877.1 Species: human Chr: chr1		Start: 42682495 End: 42682496 Strand: +
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC015208:7 GeneID: 4904 HGNC/MGI_ID: HGNC:8014 UniProt_ID: Nearer transcript ids and distances: L28809:-10 M24070:-40 BC002411:-40 BC010430:-42 BC000064:-47 BC038384:-49 BC072014:-52 BC065571:-52 BC071708:-52 BC090038:-52 BC106045:-54 J03827:-54 ENST00000332220.10:-55 Z70765:-55 BC098435:-58 BC070084:-65 DQ894802:67 DQ891609:67 AK311708:-68 AK309996:-68 M83234:-68 M85234:-68 AB385072:68 ENST00000321358.12:-77 NM_004559.5:-77 LF356427:-86 MA592004:-86 ENST00000436427.1:491 BC013838:491 view more...

Gene_name: Y-box binding protein 1 Gene_symbol: YBX1 Gene_synonyms: BP-8 CSDA2 CSDB DBPB MDR-NF1 NSEP-1 YB-1 YB1 Gene_source: HGNC:8014

TATA-Box annotation

---

Distance to TSS:	77
Nearest PromoterID:	NM_004559
Entrez ID:	4904
Nearest Unigene:	Hs.473583
Nearest Refseq:	NM_004559
Nearest Ensembl:	ENSG00000065978
Gene Name:	Y-box binding protein 1
Gene Alias:	BP-8|CBF-A|CSDA2|CSDB|DBPB|EFI-A|MDR-NF1|NSEP-1|NSEP1|YB-1|YB1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@YBX1 p2@YBX1 p3@YBX1 p4@YBX1 p5@YBX1 p6@YBX1
Sample		p1@YBX1	p2@YBX1	p3@YBX1	p4@YBX1	p5@YBX1	p6@YBX1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	88.44	3.31	5.26	0.78	0.97	2.53
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	92.46	3.44	5.46	2.23	3.64	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	95.10	3.47	5.59	1.54	1.54	1.16
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	79.01	1.66	7.69	2.29	1.04	1.46
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	87.06	2.02	5.85	2.02	0.90	1.80
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	80.24	2.91	6.59	1.94	1.36	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	82.36	6.75	7.63	3.05	2.40	3.27
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	98.58	4.84	7.02	2.18	2.91	2.18
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	93.39	3.42	6.20	2.35	1.71	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	60.28	12.75	9.85	4.64	1.16	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	57.40	9.70	6.06	6.06	1.62	3.23
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	72.37	13.01	9.35	8.13	0.41	4.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	42.07	2.58	3.55	0.00	0.81	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	37.74	3.61	1.95	0.30	1.65	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	41.72	3.51	4.17	0.22	1.98	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	38.98	2.51	3.02	0.25	2.77	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	35.82	3.06	3.28	0.87	1.75	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	36.28	1.69	3.37	0.00	2.11	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	40.52	2.13	2.67	1.60	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	44.68	3.91	2.41	0.15	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	39.69	2.14	2.54	0.40	0.94	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	32.45	2.93	2.59	0.17	1.21	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	35.55	3.10	2.46	0.13	1.16	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	37.13	1.94	2.43	0.24	1.21	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	34.83	1.55	1.29	0.26	1.29	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	41.46	4.11	0.63	0.32	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	48.35	2.20	1.10	0.55	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	41.26	2.59	3.06	0.71	2.12	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	36.67	3.55	1.45	0.32	0.81	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.42	1.27	2.17	0.36	1.81	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	34.54	1.47	2.51	0.84	1.26	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	33.80	2.34	2.54	1.37	1.37	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	32.71	1.90	2.74	0.00	0.84	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	38.10	3.79	1.48	0.16	1.15	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	36.46	3.37	2.06	0.37	2.06	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	41.58	3.07	3.45	0.38	1.34	1.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	34.34	2.04	2.04	0.61	1.43	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	35.86	2.22	1.21	0.00	1.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	47.27	2.97	1.35	0.81	2.16	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	33.37	1.68	0.72	0.48	1.92	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	34.82	2.35	0.94	0.00	1.65	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	39.23	2.78	1.76	0.15	1.76	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	37.75	1.90	2.11	0.63	1.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	36.71	1.92	2.10	0.52	1.40	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	41.16	2.01	2.01	0.40	1.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	32.80	1.86	2.56	0.70	1.86	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	36.71	2.64	2.88	0.24	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	42.03	1.79	2.98	0.89	1.49	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	43.09	2.63	2.39	0.00	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	37.61	2.02	1.82	0.20	1.01	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	45.50	2.25	1.64	0.00	1.43	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	42.47	2.22	1.78	0.22	0.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	433.76	13.99	13.99	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	36.55	1.42	2.48	0.35	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	35.46	2.65	0.66	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	78.02	4.19	0.00	0.00	4.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	42.25	1.38	1.38	0.92	1.84	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	35.98	1.62	0.32	0.00	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	34.69	1.28	1.28	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	39.29	0.63	0.94	0.00	0.94	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.02	0.00	1.41	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	31.40	1.12	1.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	48.56	0.80	0.00	0.00	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	31.26	1.02	0.68	0.00	0.68	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	37.37	0.32	0.00	0.00	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	26.98	1.06	0.00	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	323.28	16.16	0.00	0.00	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	252.72	0.00	0.00	0.00	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	28.76	0.98	0.00	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	29.75	0.99	0.00	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	27.21	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	38.09	0.33	0.33	0.00	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	28.77	0.00	0.31	0.00	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	32.71	0.31	0.31	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	50.84	4.28	0.63	1.58	2.06	0.48
Adipocyte - breast, donor2	11327-117E4	51.34	4.01	0.00	0.16	3.05	0.00
Adipocyte - omental, donor1	11473-119C6	47.96	3.44	0.64	0.64	2.80	0.13
Adipocyte - omental, donor2	11474-119C7	48.59	2.24	0.00	1.49	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	49.57	1.67	0.33	0.67	1.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	56.14	2.55	0.00	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	40.68	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	77.23	6.32	0.90	0.45	2.26	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	53.35	1.22	0.70	0.00	1.39	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	79.60	3.13	1.76	0.39	1.37	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	52.51	2.57	0.51	0.26	1.03	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	70.81	4.18	0.28	0.56	1.95	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	62.90	3.53	1.18	0.59	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	78.50	2.82	0.48	0.32	1.53	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	55.19	5.49	0.00	0.32	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	55.45	6.93	0.53	0.00	3.73	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	57.31	1.67	0.00	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	70.29	0.42	0.00	0.42	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	59.53	3.01	0.25	0.50	1.76	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	58.58	1.96	0.00	0.65	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	44.15	2.44	0.00	0.30	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	84.20	2.43	0.44	0.22	1.33	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	56.30	1.43	0.00	0.00	1.08	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	51.51	1.20	1.20	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	83.30	0.90	0.18	0.00	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	53.55	1.67	0.00	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	71.70	1.44	0.62	0.00	0.82	0.00
Anulus Pulposus Cell, donor1	11248-116E6	98.29	5.95	1.14	0.80	1.37	0.23
Anulus Pulposus Cell, donor2	11463-119B5	66.37	3.92	0.98	1.47	0.73	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	83.12	3.59	0.00	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	89.00	6.08	0.87	1.30	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	51.37	4.28	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	76.82	3.59	0.90	1.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	86.00	6.32	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	30.36	3.96	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	68.23	4.22	0.32	0.97	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	82.04	5.34	0.97	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	39.20	4.75	1.19	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	73.44	5.27	0.38	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	66.76	1.45	1.45	1.45	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	35.11	7.52	2.51	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	46.79	3.29	0.66	0.16	0.33	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	69.60	2.73	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	26.54	3.47	0.30	0.30	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	71.80	1.61	0.00	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	58.19	2.46	1.13	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	43.83	4.01	0.00	0.53	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	51.70	2.93	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	54.90	4.31	0.50	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	32.42	2.40	0.00	0.00	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	60.18	7.08	0.00	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	58.83	3.43	0.51	0.69	1.54	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	77.18	3.88	0.97	1.94	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	54.64	5.69	0.38	0.00	2.28	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	53.30	1.21	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	79.23	3.42	0.00	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	50.24	3.85	1.07	0.21	0.64	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	46.97	2.06	0.52	1.03	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	74.13	2.82	0.94	0.94	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	53.06	3.86	0.96	0.00	1.61	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	39.95	1.43	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	62.59	5.26	0.58	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	59.91	2.71	0.60	0.90	0.90	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	39.20	5.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	92.05	2.54	1.02	1.53	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	61.89	4.08	0.51	0.51	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	24.14	5.08	1.27	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	69.91	3.02	0.00	0.43	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	49.96	4.02	0.42	0.42	0.64	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	33.64	3.19	0.87	1.16	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	87.86	4.72	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	52.72	2.54	0.68	0.51	0.34	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	61.26	2.11	2.11	0.00	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	50.82	3.22	0.43	0.43	1.29	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	36.10	3.01	0.60	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	66.34	3.64	0.00	0.00	1.46	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	70.11	3.45	0.69	1.15	0.92	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	53.56	5.10	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	24.91	2.80	0.51	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	55.33	3.72	0.62	1.03	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	42.23	4.28	0.61	0.92	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	83.65	3.35	0.48	0.96	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	56.77	4.21	0.67	0.44	0.22	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	33.57	4.58	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	74.77	3.32	0.55	0.55	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	50.84	3.71	0.53	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	35.62	1.45	0.73	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	165.07	0.98	1.97	0.00	0.74	0.74
Astrocyte - cerebellum, donor2	11580-120F5	114.68	1.54	2.05	0.17	0.86	1.03
Astrocyte - cerebellum, donor3	11661-122F5	64.60	1.47	1.89	0.42	0.84	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	81.92	0.00	2.79	0.00	1.74	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	111.14	1.46	2.75	0.00	0.81	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	90.09	1.19	2.54	0.00	2.39	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	217.56	5.39	2.18	0.80	2.87	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	201.08	5.89	4.51	1.00	2.38	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	201.76	4.21	2.73	0.80	1.48	0.57
Basophils, donor1	12241-129G9	72.97	1.83	0.00	3.92	0.00	0.00
Basophils, donor2	12242-129H1	80.10	3.97	0.00	2.16	0.36	0.36
Basophils, donor3	12243-129H2	103.34	1.18	0.15	2.50	0.59	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	59.51	1.29	0.00	0.43	0.86	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	47.55	0.00	0.46	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	44.56	1.26	1.26	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	66.96	0.62	1.04	0.42	1.04	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	58.72	1.15	0.23	0.23	1.38	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	66.04	0.72	0.36	0.00	1.26	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	112.54	4.12	2.58	0.72	1.44	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	122.27	2.10	3.73	1.16	1.16	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	92.10	3.84	3.20	1.92	0.00	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	83.97	1.13	0.00	2.25	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	108.39	1.67	0.19	1.30	1.11	0.00
CD14+ Monocytes, donor3	11381-118B4	79.25	0.88	0.00	0.88	0.88	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	68.50	4.25	0.00	0.57	3.68	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	75.06	3.03	0.00	0.38	3.41	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	93.36	3.94	0.00	0.33	1.64	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	99.45	2.02	0.14	1.30	1.73	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	87.81	1.81	0.00	1.81	1.81	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	87.41	2.13	0.24	1.66	1.42	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	74.16	0.67	0.00	0.50	1.51	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	76.18	1.66	0.00	4.14	1.66	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	80.82	2.73	0.00	6.20	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	79.89	0.98	0.00	1.57	0.59	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	72.82	1.07	0.00	1.42	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	83.35	0.87	0.00	3.26	0.87	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	78.20	1.17	0.00	2.34	0.70	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	103.49	2.11	0.00	5.28	2.11	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	110.94	1.11	0.00	3.33	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	95.50	0.89	0.00	2.08	1.49	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	100.97	2.79	0.00	5.19	1.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	81.82	1.25	0.00	6.04	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	92.43	1.37	0.23	1.37	2.06	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	79.85	1.81	0.00	5.66	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	89.47	1.75	0.00	3.93	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	75.32	0.54	0.00	0.81	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	97.52	1.92	0.00	1.40	1.22	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	87.95	2.10	0.00	0.84	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	73.85	1.47	0.00	1.29	0.73	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	71.51	3.17	0.00	2.47	1.41	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	83.36	1.75	0.00	3.51	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	87.54	1.74	0.00	2.79	0.70	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	101.84	1.12	0.00	2.97	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	90.53	1.29	0.00	2.16	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	66.75	1.64	0.00	0.82	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	70.00	2.55	0.00	1.62	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	52.20	1.16	0.00	3.48	0.93	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	116.39	0.87	0.44	4.80	1.09	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	115.73	0.69	0.00	2.54	1.15	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	96.39	1.73	0.00	1.30	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	113.05	1.40	0.00	1.87	0.78	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	96.75	0.00	0.00	0.52	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	111.93	0.67	0.45	1.78	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	93.90	0.26	0.26	4.08	0.51	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	99.90	0.44	0.22	2.85	1.98	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	90.96	0.84	0.21	2.74	1.47	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	65.03	14.23	0.00	4.06	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	74.58	2.71	0.00	1.36	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	56.96	7.25	3.11	1.04	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	58.63	1.60	1.60	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	69.15	3.22	0.00	0.00	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	57.56	0.70	0.70	2.11	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	58.83	0.78	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	89.64	6.59	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	110.13	3.29	0.00	2.47	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	124.77	1.45	2.90	4.35	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	106.52	5.55	0.50	4.54	3.03	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	227.89	7.68	1.21	8.89	2.42	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	165.39	7.19	0.80	9.19	1.20	0.80
CD34+ Progenitors, donor1	11545-120B6	54.22	4.02	2.01	1.00	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	61.80	8.43	1.12	1.69	1.12	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	103.71	2.63	1.50	0.38	0.38	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	110.49	2.48	1.58	0.68	0.68	0.45
CD4+ T Cells, donor1	11225-116C1	97.83	6.78	1.07	5.36	0.36	0.71
CD4+ T Cells, donor2	11306-117C1	97.37	12.86	0.61	3.06	1.84	1.22
CD4+ T Cells, donor3	11382-118B5	72.59	8.23	0.30	5.18	0.61	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	79.38	3.06	0.51	0.77	0.26	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	77.26	3.59	0.67	0.67	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	83.65	2.87	0.00	1.15	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	63.05	4.27	0.47	0.95	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	87.09	11.94	1.40	2.81	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	9.89	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	80.21	4.91	0.29	0.72	0.58	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	75.24	4.07	0.17	1.36	0.51	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	63.19	2.10	0.64	1.13	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	78.00	8.07	0.90	4.93	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	95.73	8.39	0.70	3.84	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	83.16	6.16	0.00	4.40	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	83.91	2.53	0.00	0.84	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	54.02	1.04	0.21	0.21	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	51.12	1.00	0.00	0.33	1.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	64.99	4.08	1.09	1.36	0.54	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	68.60	3.22	2.14	0.54	0.54	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	78.90	3.59	0.00	1.79	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	113.85	1.48	0.19	0.37	0.93	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	71.70	2.82	0.22	0.00	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	81.33	3.99	0.21	1.05	1.68	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	78.37	6.57	0.51	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	81.02	9.96	0.43	2.60	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	91.09	11.77	0.87	3.05	0.00	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	85.12	6.43	0.99	0.99	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	87.70	10.16	0.00	0.00	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	64.21	16.75	1.40	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	98.86	6.92	1.11	1.11	0.28	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	100.86	12.51	0.49	1.23	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	81.62	10.78	0.00	4.62	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	75.92	9.67	1.07	0.36	1.43	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	95.56	2.77	0.00	1.38	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	69.08	8.18	1.31	3.93	1.64	0.98
CD8+ T Cells, donor2	11307-117C2	75.84	12.39	0.00	2.25	1.13	0.75
CD8+ T Cells, donor3	11383-118B6	78.27	5.30	1.01	1.77	2.02	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	89.46	4.82	1.38	1.38	0.46	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	81.00	5.27	1.92	1.20	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	69.77	6.29	1.64	1.09	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	89.76	4.50	1.20	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	101.99	5.04	1.20	2.16	0.72	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	75.26	6.37	1.59	1.82	0.91	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	89.30	4.13	1.74	1.30	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	87.12	3.68	1.58	0.79	1.32	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	105.06	2.81	1.64	0.47	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	99.02	2.72	0.91	0.60	0.30	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	101.39	2.03	0.58	0.29	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	101.78	2.13	2.13	0.80	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	58.66	2.63	0.44	2.63	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	69.68	1.37	1.37	0.91	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	58.18	5.22	0.00	0.75	2.24	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	86.80	3.96	1.80	1.08	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	83.15	6.04	0.86	1.44	0.29	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	62.22	5.66	1.41	2.12	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	95.70	6.34	1.58	0.63	1.27	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	94.42	3.08	1.23	0.92	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	84.95	6.09	2.24	2.24	0.32	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	89.88	3.06	1.91	0.76	2.29	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	97.34	2.36	1.18	1.58	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	82.45	3.78	0.76	0.00	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	44.16	12.04	0.00	11.24	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	47.56	13.29	0.70	10.49	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	62.11	13.02	1.00	18.03	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	151.70	5.48	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	104.25	0.49	0.49	0.00	2.47	0.00
Cardiac Myocyte, donor3	11686-122I3	77.98	1.05	0.42	0.00	0.95	0.11
Chondrocyte - de diff, donor1	11261-116G1	50.27	4.85	0.69	0.35	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	54.37	4.98	0.36	0.71	1.78	0.71
Chondrocyte - de diff, donor3	11410-118E6	52.68	5.46	0.80	1.02	2.16	0.46
Chondrocyte - re diff, donor2	11339-117F7	133.39	4.48	0.90	1.79	2.69	0.90
Chondrocyte - re diff, donor3	11411-118E7	50.15	2.83	0.00	1.21	2.83	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	107.07	1.03	2.07	0.11	2.07	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	94.48	1.92	2.14	0.00	0.86	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	91.51	1.77	2.04	0.09	1.68	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	243.28	5.04	2.84	0.55	2.38	3.76
Corneal Epithelial Cells, donor1	11526-119I5	73.56	0.66	0.00	0.00	0.66	0.22
Corneal Epithelial Cells, donor2	11606-120I4	75.08	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	84.36	0.77	0.26	0.26	1.79	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	67.19	2.15	0.00	0.17	1.65	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	56.77	2.52	0.00	0.32	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	67.82	2.27	0.00	0.11	1.62	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	77.21	1.02	0.34	0.34	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	75.73	0.65	0.00	0.65	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	80.33	0.00	0.00	0.48	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	87.72	4.50	0.50	0.50	1.67	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	77.45	4.11	0.00	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	93.04	5.94	0.85	1.41	0.28	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	69.20	6.68	1.18	0.39	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	72.14	3.78	0.58	0.00	1.45	0.29
Endothelial Cells - Artery, donor2	11341-117F9	73.64	2.82	0.24	0.47	1.18	0.47
Endothelial Cells - Artery, donor3	11413-118E9	70.47	2.98	1.23	0.70	1.05	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	50.54	5.54	0.22	1.11	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	61.77	5.48	0.61	0.61	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	54.69	5.36	0.28	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	69.53	3.57	0.00	0.00	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	68.73	5.73	0.00	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	68.20	3.69	0.28	0.28	0.85	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	107.63	4.80	1.20	0.80	1.60	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	65.52	1.57	0.52	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	106.98	4.60	0.99	0.50	2.24	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	73.65	8.04	0.87	1.52	2.39	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	83.78	5.25	0.98	0.61	1.10	0.24
Endothelial Cells - Vein, donor1	11267-116G7	60.29	2.28	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	57.98	3.49	0.70	0.70	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	74.42	3.77	1.41	0.31	1.10	0.00
Eosinophils, donor1	12244-129H3	152.47	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	49.51	0.00	0.00	8.25	1.65	0.00
Eosinophils, donor3	12246-129H5	21.40	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	76.72	0.98	0.24	0.49	1.22	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	52.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	38.59	2.87	0.00	0.00	1.23	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	29.78	3.50	0.33	0.33	3.18	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	66.52	4.12	0.11	0.76	2.38	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	68.40	4.00	1.82	0.49	3.40	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	36.57	0.96	0.55	0.55	0.27	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	64.97	6.96	0.95	0.95	1.27	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	46.37	0.53	0.79	1.32	0.26	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	90.36	4.65	0.66	2.33	4.32	1.33
Fibroblast - Cardiac, donor1	11268-116G8	72.13	2.27	0.91	0.45	2.27	0.45
Fibroblast - Cardiac, donor2	11345-117G4	72.01	0.76	0.76	0.00	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	49.84	3.15	1.26	0.47	1.58	0.16
Fibroblast - Cardiac, donor4	11452-119A3	67.59	3.64	0.91	1.21	0.61	0.91
Fibroblast - Cardiac, donor5	11456-119A7	67.51	3.93	0.63	0.51	1.90	0.00
Fibroblast - Cardiac, donor6	11460-119B2	70.95	2.43	0.61	0.15	0.76	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	92.99	1.34	1.88	0.40	0.80	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	59.97	1.73	0.43	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	128.90	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	153.14	4.38	2.31	0.92	1.85	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	68.18	6.28	1.87	1.02	0.68	0.85
Fibroblast - Dermal, donor1	11269-116G9	107.53	5.40	0.94	0.47	2.82	0.00
Fibroblast - Dermal, donor2	11346-117G5	105.66	6.13	3.30	0.00	1.89	1.89
Fibroblast - Dermal, donor3	11418-118F5	85.71	4.59	1.09	1.21	2.66	0.60
Fibroblast - Dermal, donor4	11450-119A1	106.38	2.83	2.15	0.57	2.94	0.68
Fibroblast - Dermal, donor5	11454-119A5	101.01	2.09	2.27	0.17	2.27	1.22
Fibroblast - Dermal, donor6	11458-119A9	102.65	2.60	2.27	0.32	1.62	1.30
Fibroblast - Gingival, donor1	11237-116D4	103.70	2.08	1.67	1.04	0.83	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	73.36	4.72	0.26	1.31	2.36	0.26
Fibroblast - Gingival, donor2	11318-117D4	98.44	2.64	0.79	0.13	1.32	0.53
Fibroblast - Gingival, donor3	11394-118C8	95.24	6.09	2.03	0.77	1.16	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	63.37	4.16	1.04	0.00	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	53.39	6.17	2.64	1.94	1.94	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	87.30	3.59	0.94	1.09	0.62	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	83.30	2.84	1.22	0.54	1.08	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	42.35	1.76	0.71	0.35	0.35	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	75.02	4.24	0.29	0.44	1.17	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	83.72	3.27	0.27	0.82	0.55	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	77.22	2.96	0.33	0.88	0.88	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	38.01	5.28	1.17	1.32	1.17	0.15
Fibroblast - Lung, donor1	11270-116H1	61.17	1.36	1.36	0.00	2.72	0.00
Fibroblast - Lung, donor2	11347-117G6	105.94	2.98	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	104.46	2.53	0.63	0.63	1.27	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	216.59	5.00	1.67	0.83	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	145.46	2.80	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	66.05	1.68	0.00	0.00	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	209.48	3.65	0.81	0.41	1.62	0.41
Fibroblast - Mammary, donor2	11620-122A9	119.83	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	23.83	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	108.63	1.75	1.16	0.39	2.13	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	126.65	2.73	2.28	0.46	3.64	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	96.39	6.73	1.22	0.92	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	86.25	3.82	0.38	0.76	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	61.83	7.56	1.08	0.81	1.89	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	44.88	7.42	1.28	0.58	1.97	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	67.54	3.09	0.44	0.22	1.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	133.50	2.24	1.22	0.00	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	104.24	2.00	1.34	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	79.07	1.19	1.19	0.00	1.19	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	88.11	0.79	0.00	0.20	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	48.49	4.09	0.00	0.36	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	61.69	3.74	0.59	0.00	0.59	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	92.06	0.00	0.00	0.30	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	88.41	4.97	0.54	1.08	1.40	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	56.44	0.25	0.00	0.00	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	69.08	2.46	0.16	0.16	0.66	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	79.20	2.01	0.20	0.80	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	85.19	2.91	0.50	0.00	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	107.90	1.21	0.00	1.21	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	52.03	4.23	0.25	0.41	0.50	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	66.33	5.13	0.51	0.34	0.85	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	71.27	0.00	0.33	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	89.58	2.66	0.53	0.21	0.75	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	84.00	2.36	1.01	0.67	0.84	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	64.92	1.88	0.31	0.16	2.82	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	310.24	0.00	0.00	22.16	66.48	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	58.39	2.61	0.00	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	48.71	4.33	0.00	1.04	1.04	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	53.61	1.56	0.26	0.00	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	47.78	3.07	0.77	0.51	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	96.46	6.89	3.83	0.00	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	102.09	1.28	8.93	0.64	1.91	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	77.88	2.00	9.41	0.00	3.71	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	120.78	1.10	3.31	0.00	3.31	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	74.21	2.97	7.31	0.46	2.51	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	74.70	0.99	7.13	0.20	2.97	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	106.26	0.00	3.44	0.00	3.97	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	103.06	3.26	7.50	0.65	3.59	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	55.28	0.88	8.84	0.00	3.10	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	109.81	1.55	6.92	0.42	1.41	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	95.31	3.57	4.68	0.37	1.48	1.97
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	79.51	1.61	5.10	1.34	2.15	1.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	105.31	2.48	2.97	0.25	2.23	1.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	96.34	1.38	1.66	0.28	1.66	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	83.15	2.85	3.66	0.00	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	81.69	1.37	1.14	0.46	1.60	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	85.70	2.62	1.12	0.12	1.37	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	82.40	3.06	1.75	0.22	0.87	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	87.46	1.77	2.36	0.00	1.48	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	86.63	0.79	1.43	0.64	1.11	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	65.24	1.34	1.12	0.00	1.79	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	103.03	0.81	0.60	0.20	1.81	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	117.05	0.85	1.70	0.17	1.53	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	77.59	2.48	0.98	0.62	2.31	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	106.45	2.08	2.71	0.21	2.60	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	104.69	1.20	1.37	0.00	1.20	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	112.65	1.00	0.44	0.11	1.55	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	76.12	1.83	1.66	0.50	1.58	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	85.96	1.43	1.63	0.00	0.41	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	85.62	1.03	1.44	0.21	1.86	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	92.35	0.58	1.50	0.12	2.42	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	85.55	1.00	1.17	0.33	2.33	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	72.74	2.20	0.88	0.44	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	90.03	1.48	2.21	0.12	1.48	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	75.54	0.65	1.78	0.16	1.46	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	63.18	1.92	2.25	0.00	2.57	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	93.14	1.42	1.14	0.09	1.90	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	65.01	0.79	0.47	0.16	1.42	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	85.75	0.91	0.91	0.30	1.52	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	95.97	1.25	1.05	0.31	2.82	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	65.87	0.88	0.66	0.22	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	71.54	1.40	1.96	0.00	1.40	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	76.11	1.76	0.74	0.28	1.67	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	64.71	1.87	0.27	0.53	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	78.80	1.22	0.77	0.00	1.84	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	95.60	1.17	0.39	0.13	1.42	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	75.36	0.54	1.90	0.00	3.80	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	65.81	1.47	0.92	0.00	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	67.77	1.54	0.00	0.00	1.32	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	52.56	0.99	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	72.16	1.45	0.66	0.26	1.19	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	55.48	1.41	0.00	0.20	1.01	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	59.98	3.81	0.76	0.00	2.03	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	130.58	1.99	8.36	1.19	1.00	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	105.85	1.08	6.16	0.62	2.16	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	130.52	3.07	12.68	0.20	1.64	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	50.38	0.31	6.26	0.00	1.25	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	62.16	0.28	4.24	0.00	1.13	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	85.78	0.46	6.00	0.46	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	76.72	2.47	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	101.34	2.32	5.42	0.77	3.09	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	154.03	0.00	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	99.11	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	90.48	0.00	2.60	0.00	2.60	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	87.30	0.41	0.82	0.00	3.71	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	93.30	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	87.53	0.00	3.36	0.00	4.75	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	81.38	0.65	2.29	0.00	3.60	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	97.31	0.00	0.84	0.00	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	92.24	0.32	2.23	0.00	2.86	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	79.48	0.00	1.70	0.00	3.40	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	91.88	0.00	0.00	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	115.69	0.57	2.86	0.00	5.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	75.18	0.00	1.18	0.00	2.66	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	54.21	0.00	1.69	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	101.48	0.00	2.07	0.00	3.31	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	96.42	0.69	2.30	0.00	2.76	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	0.00	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	78.42	0.77	1.15	0.00	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	62.91	0.00	0.65	0.00	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	57.52	0.67	0.67	0.00	2.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	87.46	0.77	2.70	0.00	3.85	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	71.21	0.68	1.71	0.34	2.74	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	34.79	0.00	0.00	0.00	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	62.76	0.94	3.30	0.00	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	76.64	1.21	1.21	0.00	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	73.25	0.00	5.60	0.51	2.54	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	81.76	0.80	1.99	0.00	1.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	61.18	1.48	0.99	0.00	1.48	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	44.86	0.00	3.54	0.00	0.00	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	64.18	0.00	0.58	0.00	2.33	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	56.62	0.44	2.63	0.00	2.19	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	49.17	0.85	1.70	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	50.74	0.60	0.60	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	64.54	0.00	1.46	0.49	3.40	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	57.07	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	53.22	0.42	1.25	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	49.48	3.37	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	58.04	5.39	0.95	1.27	0.63	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	71.02	3.76	0.84	1.67	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	113.49	1.16	0.93	0.46	1.16	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	127.45	1.35	0.51	0.84	1.18	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	131.04	0.46	1.59	0.68	2.96	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	119.58	0.98	0.77	0.77	1.64	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	132.82	1.07	1.50	0.64	1.72	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	117.54	0.65	2.15	0.65	2.15	1.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	110.22	0.75	0.87	0.75	1.62	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	115.80	2.06	1.37	0.86	1.20	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	115.97	1.28	0.64	0.96	0.96	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	104.09	5.04	0.56	0.00	1.68	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	90.45	1.30	0.43	0.43	2.60	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	84.60	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	106.17	2.47	0.71	0.35	0.71	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	61.75	1.45	0.73	0.00	2.18	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	83.22	1.57	0.52	0.52	0.52	0.35
Hepatocyte, donor1	11523-119I2	42.37	0.00	1.21	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	57.10	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	52.76	3.07	0.61	0.61	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	93.99	0.00	1.96	0.00	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	28.84	0.87	0.52	0.87	1.40	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	82.46	1.10	0.96	0.00	0.96	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	0.00	6.37	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	80.10	0.00	0.00	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	67.83	1.38	5.54	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	154.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	61.51	0.00	7.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	58.48	4.87	3.25	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	78.36	16.67	3.33	5.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	0.00	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	52.94	5.29	0.00	1.32	0.00	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	77.61	1.11	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	5.24	5.24	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	71.80	3.78	6.30	1.26	0.00	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	60.32	1.55	6.19	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	61.37	1.29	3.88	0.00	0.65	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	46.69	1.61	3.22	1.61	3.22	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	55.41	3.26	4.89	1.63	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	38.20	2.52	5.46	1.68	0.42	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	75.55	2.41	4.02	0.80	0.80	3.21
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	88.64	3.69	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	114.23	3.78	4.25	1.42	0.94	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	64.40	3.63	4.53	1.81	0.91	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	86.09	2.15	5.38	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	63.52	1.27	2.54	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	63.77	0.64	2.55	0.64	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	3.65	1.82	1.82	1.82	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	59.27	2.86	5.71	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	0.00	3.32	0.00	0.00	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	98.15	4.94	2.78	0.62	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	84.29	1.76	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	78.58	0.00	3.14	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	60.50	2.78	8.34	3.48	1.39	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	64.18	4.43	4.43	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	58.36	3.24	0.00	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	44.47	2.62	2.62	1.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	78.74	2.25	2.25	2.25	0.00	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	48.78	3.48	6.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	62.94	2.13	7.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	59.57	5.54	2.77	1.39	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	2.85	5.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	75.47	2.76	6.44	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	54.46	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	31.72	0.00	0.00	1.06	0.00	2.11
Keratinocyte - epidermal, donor1	11272-116H3	56.39	1.06	0.16	0.16	1.39	0.16
Keratinocyte - epidermal, donor2	11349-117G8	36.90	0.00	0.00	0.59	1.17	0.00
Keratinocyte - epidermal, donor3	11421-118F8	73.07	1.04	0.76	0.09	1.51	0.28
Keratinocyte - oral, donor1	11251-116E9	117.94	2.16	1.14	0.45	1.25	0.57
Keratocytes, donor1	11527-119I6	72.55	6.88	2.41	4.13	0.69	3.78
Keratocytes, donor2	11607-120I5	130.07	5.86	1.17	1.17	2.34	0.00
Keratocytes, donor3	11688-122I5	41.89	3.16	1.98	3.36	0.00	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	2.20	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	105.72	1.08	2.16	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	84.65	1.27	0.69	0.23	0.46	0.23
Lens Epithelial Cells, donor3	11690-122I7	76.09	1.21	1.61	0.20	0.61	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	65.57	4.39	0.36	0.59	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	63.63	4.74	0.00	0.56	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	62.96	7.40	0.47	0.79	0.63	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	75.28	8.07	1.08	0.00	1.08	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	65.87	4.73	0.00	0.32	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	62.86	4.74	0.54	0.32	1.08	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	73.87	5.34	0.82	0.82	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	61.69	3.54	0.00	0.25	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	56.72	5.21	0.28	0.28	1.69	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	69.61	5.93	0.00	0.79	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	65.53	3.10	0.19	0.19	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	46.66	4.44	0.56	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	64.46	4.18	0.70	1.05	1.05	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	71.08	3.82	0.72	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	59.33	6.18	0.27	0.00	1.24	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	78.84	7.39	0.31	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	56.11	0.94	0.31	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	58.92	5.31	0.55	0.55	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	63.19	5.59	0.00	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	64.43	4.69	0.29	0.00	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	57.25	3.49	0.25	0.00	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	70.32	5.33	0.48	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	69.75	5.39	0.00	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	71.30	7.87	0.76	0.15	1.67	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	76.73	10.37	0.00	0.52	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	77.68	3.98	0.84	0.84	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	59.70	4.21	0.45	0.60	1.05	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	70.85	5.50	2.06	1.38	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	65.10	4.70	0.75	0.38	0.38	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	66.27	5.73	0.11	0.64	1.27	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	64.93	5.33	0.48	1.45	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	62.52	4.30	0.33	0.66	0.99	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	63.31	4.58	0.25	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	67.75	6.66	0.37	0.74	2.22	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	57.57	4.69	0.49	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	63.93	3.85	0.27	0.41	1.51	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	72.37	4.18	0.00	0.00	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	68.78	6.39	1.52	0.91	1.22	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	72.50	5.32	0.42	0.14	2.10	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	66.13	5.69	1.42	0.00	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	68.35	3.88	0.00	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	51.51	3.11	0.31	0.31	0.78	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	74.84	4.66	0.72	0.00	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	78.73	2.94	0.00	0.98	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	55.80	4.00	0.24	0.24	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	70.04	5.82	0.25	0.37	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	70.44	4.10	0.00	1.28	1.02	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	68.92	5.37	0.00	0.30	2.09	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	40.79	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	31.45	0.77	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.98	0.74	0.00	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	30.47	1.69	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	29.54	0.00	0.00	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	32.69	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	23.70	1.55	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	3.57	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	23.52	2.04	0.45	0.68	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	30.83	1.74	0.00	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	46.37	3.15	0.45	0.45	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	26.28	1.90	0.41	0.41	0.68	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	24.14	1.54	0.51	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	37.05	2.12	1.06	0.00	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	37.98	4.00	2.00	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	22.41	2.04	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	44.02	2.67	0.27	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	39.68	2.83	0.57	0.38	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	0.61	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	40.77	3.26	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	43.73	2.71	0.83	0.42	0.83	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	31.11	2.80	0.00	0.00	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	34.00	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	41.80	2.61	0.00	0.29	2.61	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	32.28	1.79	0.90	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	44.81	2.77	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	30.40	1.06	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.45	0.37	0.37	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	35.69	0.00	0.00	0.00	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	30.32	1.15	0.77	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.12	2.26	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	33.64	1.64	0.00	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	26.66	1.81	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	35.19	2.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	51.54	2.24	0.75	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.44	1.86	0.74	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	35.75	1.72	0.86	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	34.25	1.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	39.98	3.00	0.33	0.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	30.17	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	36.97	0.00	1.42	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	33.68	1.72	1.03	0.34	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	26.30	1.07	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	26.26	0.00	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	39.26	1.11	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	2.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	39.14	1.06	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	36.81	0.80	0.80	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	17.44	0.73	0.73	2.18	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	32.19	0.77	0.77	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	27.62	1.97	0.49	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	18.82	2.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	27.66	1.01	0.50	0.00	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	30.19	0.00	0.90	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	27.54	3.44	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	34.29	2.67	0.45	0.45	1.34	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	28.54	2.35	0.39	0.78	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	29.03	3.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	28.02	0.00	0.00	1.56	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	28.00	2.19	0.44	0.00	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	26.84	0.56	0.00	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	32.68	0.44	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	37.03	1.54	0.39	0.00	1.16	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	28.86	1.52	1.01	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	33.64	0.96	0.96	0.00	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	36.57	3.18	0.40	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	35.24	2.43	0.00	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.13	0.69	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	35.34	1.52	1.52	0.00	1.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	30.99	4.65	0.00	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	30.23	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	43.42	2.22	0.32	0.63	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.86	2.13	0.00	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	21.26	1.15	1.15	0.57	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	23.14	1.54	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	22.64	0.71	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	34.05	0.00	1.13	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	32.45	1.66	0.00	0.83	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	27.41	4.70	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.65	0.84	0.42	0.42	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.88	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	26.76	0.67	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	37.96	2.14	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	32.73	0.40	0.00	0.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	19.27	2.75	0.00	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	41.79	3.56	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	32.48	0.57	1.71	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	23.01	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	48.15	1.64	0.55	0.00	1.64	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	30.74	1.78	0.00	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.52	2.08	1.04	0.26	0.00	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	35.14	1.33	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	82.51	3.65	0.00	0.00	1.14	0.00
Macrophage - monocyte derived, donor2	11313-117C8	70.28	1.28	0.00	0.18	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	88.09	2.75	0.00	0.26	1.05	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	40.36	2.66	0.53	0.53	0.53	1.06
Mallassez-derived cells, donor2	11929-125I3	55.46	1.11	0.48	0.16	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	82.28	1.95	0.28	0.97	1.25	0.56
Mammary Epithelial Cell, donor1	11273-116H4	82.50	4.68	1.00	1.10	1.89	0.90
Mammary Epithelial Cell, donor2	11350-117G9	89.18	2.90	0.29	0.58	0.87	0.29
Mammary Epithelial Cell, donor3	11422-118F9	64.85	2.00	0.00	0.00	1.00	0.25
Mast cell - stimulated, donor1	11487-119E2	197.96	21.69	0.68	3.39	4.07	0.00
Mast cell, donor1	11563-120D6	67.05	9.95	0.11	1.08	1.19	0.22
Mast cell, donor2	11565-120D8	86.18	24.67	0.89	2.97	3.86	1.19
Mast cell, donor3	11566-120D9	71.81	31.29	0.68	2.03	3.60	0.00
Mast cell, donor4	11567-120E1	57.44	32.44	1.06	1.42	2.48	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	78.84	4.99	0.11	0.11	0.78	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	49.61	1.75	0.00	1.17	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	69.18	8.26	0.00	0.69	1.15	0.00
Mast cell, expanded, donor8	11941-126A6	64.60	6.19	0.33	0.33	2.01	0.33
Melanocyte - dark, donor1	11502-119F8	105.17	5.17	0.50	0.00	0.50	0.10
Melanocyte - dark, donor2	11582-120F7	98.98	1.38	0.35	0.00	2.42	0.00
Melanocyte - dark, donor3	11663-122F7	85.91	2.03	0.14	0.14	0.58	0.00
Melanocyte - light, donor1	11274-116H5	63.00	0.94	0.00	0.24	2.12	0.00
Melanocyte - light, donor2	11351-117H1	37.54	0.00	0.68	0.00	3.41	0.00
Melanocyte - light, donor3	11423-118G1	58.97	0.87	0.87	0.00	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	64.45	0.52	0.00	0.10	2.08	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	59.44	0.27	0.00	0.00	1.88	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	73.93	0.80	0.27	0.00	3.48	0.00
Meningeal Cells, donor1	11493-119E8	208.79	3.23	1.86	0.62	0.62	0.62
Meningeal Cells, donor2	11573-120E7	145.69	1.32	4.40	0.44	1.32	0.00
Meningeal Cells, donor3	11654-122E7	124.05	2.53	1.55	0.57	1.22	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	98.66	2.28	1.14	0.57	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	39.25	3.42	0.40	0.40	0.60	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	26.28	3.94	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	78.49	2.62	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	78.94	4.31	0.72	0.72	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	49.34	6.78	0.42	0.21	1.27	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	64.84	6.53	1.01	1.01	2.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	103.06	3.08	0.88	0.44	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	101.55	1.46	2.19	0.00	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	103.32	2.86	0.82	1.23	0.82	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	81.30	2.08	1.39	0.69	0.28	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	35.69	1.12	0.00	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	48.29	0.92	0.79	0.00	0.92	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.49	1.78	0.59	0.89	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	99.90	1.28	1.28	0.00	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	99.95	5.32	1.06	1.42	2.84	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	42.84	0.63	0.00	0.31	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	95.79	2.18	2.18	0.00	2.18	0.73
Mesothelial Cells, donor1	11247-116E5	32.35	3.71	1.33	0.27	1.33	0.00
Mesothelial Cells, donor2	12156-128G5	37.03	4.50	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	41.41	2.46	0.51	0.07	1.08	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	4.05	0.00	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	105.65	4.68	0.00	0.25	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	72.44	6.77	0.00	1.18	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	68.19	3.41	0.00	0.31	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	66.79	4.56	0.00	0.00	1.04	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	46.32	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	73.08	3.50	0.00	0.25	1.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	65.63	4.19	0.00	0.00	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	74.99	3.66	0.00	0.20	1.42	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	69.69	4.75	0.00	0.00	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	76.96	17.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	85.84	1.77	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	58.51	3.04	0.00	0.76	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	39.48	9.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	87.01	4.88	0.00	0.42	1.70	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	33.15	6.45	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	75.11	2.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	10.06	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	69.50	3.51	0.00	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	55.85	3.09	0.00	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	54.18	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	86.11	2.76	0.00	1.15	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	58.47	2.73	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	54.22	2.04	0.00	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	73.59	4.29	0.00	0.21	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	46.68	3.78	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	55.63	2.41	0.00	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	41.06	6.59	0.00	0.51	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	29.83	9.94	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	50.01	3.53	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	55.29	4.41	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	30.53	5.45	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	73.04	1.92	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	44.03	6.40	0.00	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	45.25	2.74	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	95.11	2.50	0.00	0.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	28.54	6.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	66.56	6.13	0.00	0.44	1.31	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	40.84	6.62	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	44.83	4.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	77.85	3.97	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	31.32	3.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	50.83	8.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	65.64	5.47	0.00	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	33.26	5.69	0.00	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	56.11	3.20	0.00	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	59.20	4.21	0.28	0.00	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	41.15	3.33	0.00	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	29.72	2.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	52.49	3.02	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	42.16	3.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	86.63	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	39.71	2.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	47.81	5.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	47.67	2.07	0.00	0.69	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	38.09	1.55	0.26	0.00	1.81	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	40.75	3.00	0.00	0.86	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	29.85	1.91	0.00	1.27	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	37.36	2.40	0.00	0.27	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	37.42	2.99	0.00	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	34.47	2.40	0.00	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	31.21	0.96	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	34.72	3.76	0.00	1.11	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	33.75	4.55	0.00	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	39.77	2.27	0.00	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	40.07	3.69	0.00	0.25	0.98	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	44.31	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.93	2.35	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	39.79	2.31	0.00	0.00	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	37.92	2.47	0.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	40.50	4.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	52.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	115.85	0.00	0.00	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	98.90	3.29	0.00	0.00	2.63	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	86.26	4.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	62.86	5.73	0.00	0.20	0.99	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	99.65	13.04	0.00	1.86	2.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	92.00	7.51	0.00	0.00	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	99.88	3.20	0.00	0.27	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	67.18	4.64	0.00	0.23	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	67.78	4.42	0.00	0.74	2.21	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	92.71	3.66	0.00	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	101.11	0.00	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	125.59	7.48	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	61.82	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	108.06	10.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	121.43	5.06	0.00	0.00	1.69	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	170.24	12.26	0.00	1.36	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	64.22	1.91	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	97.18	0.81	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	190.31	10.57	0.00	1.51	6.04	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	11.42	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	130.50	13.05	0.00	13.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	57.03	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	25.10	0.00	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	73.03	2.80	0.65	0.86	1.51	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	74.21	5.75	2.09	0.00	1.57	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	44.72	5.34	0.67	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	30.47	2.50	0.42	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	85.18	3.80	0.76	2.47	0.76	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	76.60	15.96	1.60	1.60	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	37.40	2.72	2.72	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	181.93	11.03	0.00	5.51	7.35	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	36.83	3.35	1.26	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	46.49	6.74	0.70	0.46	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	34.59	5.13	0.81	0.00	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	65.17	5.68	1.26	1.47	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	801.70	11.13	0.00	11.13	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	51.12	3.97	1.49	0.99	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	40.87	6.50	0.54	0.81	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	29.47	4.53	1.13	0.45	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	38.21	4.90	0.82	0.33	0.49	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	46.48	5.47	0.36	1.09	0.73	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	34.48	4.24	0.53	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	28.81	6.00	0.00	1.20	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	45.94	7.88	0.33	1.31	1.64	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	21.63	4.07	0.16	0.49	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	47.45	5.82	0.71	1.41	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	30.24	1.41	0.70	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	24.82	6.90	0.46	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	23.14	3.86	0.64	0.00	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	51.39	7.24	0.34	2.07	2.07	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	202.28	15.17	0.00	0.00	12.64	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	44.33	5.79	0.22	1.11	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	24.98	3.81	0.42	0.42	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.96	4.27	0.00	1.19	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	34.34	2.58	0.86	0.43	0.86	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	225.69	0.00	9.03	0.00	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	32.66	2.33	0.00	1.33	1.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	46.44	5.86	0.45	0.90	0.00	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	28.17	3.57	0.40	1.59	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	39.93	2.79	1.86	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.03	4.16	0.00	1.51	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.18	2.61	0.65	0.65	0.33	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	24.84	2.61	0.87	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	41.61	5.43	1.81	1.36	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	2.65	0.88	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	29.25	6.65	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	37.20	3.97	0.99	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	28.33	1.15	0.00	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	29.34	3.33	0.91	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	57.25	5.30	0.66	0.44	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	27.11	4.07	0.00	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	270.81	15.33	15.33	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.22	2.44	0.61	0.00	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.98	2.20	0.63	0.94	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	28.75	1.82	0.61	0.91	0.91	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.90	0.00	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	58.95	2.27	0.00	2.27	4.53	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	237.72	15.17	0.00	5.06	30.35	0.00
Myoblast, donor1	11241-116D8	53.67	4.72	0.99	1.24	1.74	0.50
Myoblast, donor2	11322-117D8	74.41	5.75	0.58	0.77	1.92	0.00
Myoblast, donor3	11398-118D3	73.66	6.05	0.67	0.67	1.01	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	82.60	4.52	2.19	0.29	0.73	0.73
Natural Killer Cells, donor1	11230-116C6	71.04	5.54	0.31	1.85	0.92	1.54
Natural Killer Cells, donor2	11311-117C6	73.88	8.75	0.60	3.32	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	73.07	5.52	1.10	2.39	1.29	0.18
Neural stem cells, donor1	11275-116H6	135.38	6.17	2.90	1.45	1.45	1.81
Neural stem cells, donor2	11352-117H2	252.26	7.70	11.55	0.00	7.70	1.93
Neurons, donor1	11494-119E9	139.96	4.55	10.24	1.14	2.28	1.14
Neurons, donor2	11574-120E8	116.91	5.28	10.79	0.44	1.10	2.86
Neurons, donor3	11655-122E8	69.06	4.11	13.15	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	14.85	2.78	0.00	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	28.10	0.00	0.00	0.61	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	57.35	5.34	2.14	0.36	0.36	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	69.03	2.60	1.30	0.33	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	62.37	3.41	2.21	0.60	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	33.04	2.89	0.41	0.28	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	40.24	4.05	0.58	1.01	0.43	0.14
Olfactory epithelial cells, donor3	11935-125I9	45.29	4.65	0.57	0.57	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	44.71	3.02	0.58	0.49	0.39	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	67.40	1.20	0.60	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	96.56	5.53	0.43	1.49	2.55	0.21
Osteoblast - differentiated, donor2	11353-117H3	51.44	5.72	1.14	1.14	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	63.93	5.59	0.62	0.62	1.86	1.24
Osteoblast, donor1	11277-116H8	99.87	5.08	1.37	0.78	1.37	0.39
Osteoblast, donor2	11354-117H4	125.71	2.81	1.40	0.70	0.70	0.00
Osteoblast, donor3	11426-118G4	129.57	3.38	1.24	0.53	2.49	0.00
Pancreatic stromal cells, donor1	11249-116E7	88.62	7.50	0.76	2.19	1.85	0.42
Pericytes, donor1	11491-119E6	74.88	2.56	1.34	0.11	0.89	0.00
Pericytes, donor2	11571-120E5	70.85	3.17	2.72	0.45	0.68	0.68
Pericytes, donor3	11652-122E5	88.70	2.44	0.61	0.00	2.44	0.61
Perineurial Cells, donor1	11499-119F5	99.57	1.36	1.81	0.11	0.45	0.11
Perineurial Cells, donor2	11579-120F4	104.25	3.22	0.55	0.18	1.47	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	85.42	3.51	0.32	1.59	1.59	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	69.30	1.71	0.00	1.71	1.22	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	68.98	2.85	0.52	1.68	1.16	0.00
Placental Epithelial Cells, donor1	11278-116H9	31.33	1.91	1.20	2.39	1.20	0.24
Placental Epithelial Cells, donor2	11355-117H5	46.57	2.22	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	44.76	0.98	0.39	0.20	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	35.44	1.58	0.32	0.95	1.58	0.00
Preadipocyte - breast, donor1	11467-119B9	44.46	2.81	0.75	0.56	1.50	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	54.56	0.91	0.13	0.26	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	55.16	2.03	0.23	0.23	1.35	0.23
Preadipocyte - omental, donor1	11468-119C1	43.16	3.84	0.21	0.64	2.13	0.32
Preadipocyte - omental, donor2	11329-117E6	38.41	1.75	0.44	0.44	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	50.71	1.58	0.29	0.29	1.86	0.00
Preadipocyte - perirenal, donor1	11469-119C2	54.13	1.97	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	54.36	3.07	0.61	0.61	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	109.96	6.37	1.24	1.95	2.83	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	89.06	1.70	0.34	0.51	3.07	0.17
Preadipocyte - visceral, donor1	11280-116I2	109.35	8.10	2.05	1.58	1.58	0.47
Preadipocyte - visceral, donor2	11357-117H7	63.50	4.60	0.46	0.00	1.84	0.00
Preadipocyte - visceral, donor3	11429-118G7	89.44	5.12	1.67	1.04	2.30	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	28.21	0.30	0.91	0.75	3.92	0.15
Prostate Epithelial Cells, donor2	11331-117E8	46.58	1.49	0.27	0.27	2.30	0.41
Prostate Epithelial Cells, donor3	11404-118D9	59.83	0.92	0.31	0.31	3.31	0.18
Prostate Stromal Cells, donor1	11254-116F3	70.39	3.53	1.94	1.14	1.37	0.11
Prostate Stromal Cells, donor2	11332-117E9	78.89	5.02	1.79	1.08	3.05	0.36
Prostate Stromal Cells, donor3	11405-118E1	55.58	7.82	0.83	0.94	2.29	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	99.64	3.28	1.09	0.00	2.55	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	69.17	1.32	0.14	0.14	0.90	0.07
Renal Epithelial Cells, donor1	11517-119H5	103.48	0.51	3.04	0.00	1.01	1.01
Renal Epithelial Cells, donor2	11597-120H4	112.39	2.85	0.71	0.00	2.13	2.13
Renal Epithelial Cells, donor3	11678-122H4	71.46	1.38	0.64	0.21	0.95	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	76.26	1.36	0.00	0.68	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	81.40	3.64	0.67	0.67	1.08	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	113.67	3.33	1.11	0.44	1.33	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	48.58	1.33	0.67	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	100.36	2.86	0.66	0.44	0.44	0.66
Renal Mesangial Cells, donor2	11598-120H5	118.50	3.13	1.25	0.00	1.88	0.63
Renal Mesangial Cells, donor3	11679-122H5	69.08	1.66	0.55	0.00	1.66	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	113.01	1.88	0.81	0.00	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	82.65	0.00	0.84	0.00	2.11	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	109.15	2.89	0.96	0.00	1.93	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	92.56	1.04	1.56	0.52	1.04	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	86.41	1.14	2.56	0.85	0.57	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	79.24	1.03	2.06	1.03	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	60.47	3.01	2.76	1.00	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	54.39	2.54	0.27	0.00	1.34	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	27.70	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	36.87	0.00	0.00	0.00	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	40.02	1.16	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	52.53	0.65	1.17	0.13	0.39	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	44.19	0.70	0.60	0.00	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	35.13	0.67	0.89	0.11	0.33	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	65.87	0.50	0.50	0.50	1.61	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.57	0.58	0.70	0.12	0.58	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	52.24	0.46	0.46	0.23	0.69	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	58.05	0.14	0.96	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	43.57	0.00	1.21	0.30	0.76	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	36.38	0.18	0.54	0.18	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	61.40	0.57	0.57	0.29	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	49.47	0.21	0.64	0.32	0.75	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	49.34	0.89	0.44	0.00	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	69.01	0.38	0.00	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.09	0.09	0.75	0.28	0.65	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	40.96	0.56	1.13	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	56.80	0.27	0.53	0.13	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	47.02	0.29	0.58	0.29	0.97	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	49.65	0.76	0.57	0.19	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	52.97	0.32	0.64	0.32	0.32	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	38.40	0.56	0.00	0.28	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	42.90	0.17	0.68	0.00	0.68	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	61.26	0.18	0.18	0.55	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	48.44	0.37	0.98	0.00	0.74	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	49.97	0.81	0.67	0.54	0.67	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	72.65	0.24	1.65	0.00	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	43.65	0.20	1.19	0.60	1.19	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	45.13	0.00	0.94	0.23	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	73.61	0.41	0.83	0.41	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	49.33	0.22	0.22	0.22	0.66	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	39.06	1.25	0.84	0.00	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	67.97	0.40	0.94	0.27	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	50.58	0.34	0.68	0.00	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	38.56	0.58	0.77	0.19	1.35	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	77.89	0.52	0.52	0.17	0.52	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	55.00	0.82	0.82	0.41	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	47.61	0.66	0.33	0.16	0.99	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	61.87	0.34	0.85	0.00	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	63.47	0.44	0.44	0.30	1.48	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	42.91	1.07	0.53	0.00	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	45.07	0.69	0.55	0.55	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	49.29	0.95	0.24	0.00	0.95	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	47.97	0.81	0.60	0.81	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	56.32	0.28	0.57	0.09	0.85	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	35.63	1.75	0.35	0.35	1.05	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	30.22	0.91	0.60	0.91	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	59.36	0.37	0.61	0.49	0.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	22.56	0.87	0.29	0.58	1.02	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	29.20	2.43	0.00	1.22	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	55.46	0.00	0.00	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	33.93	0.23	0.45	0.90	1.13	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	35.65	0.60	0.90	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	33.53	0.35	0.24	0.71	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	32.23	1.28	0.85	0.43	3.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	28.85	0.60	0.60	0.00	1.20	0.00
Schwann Cells, donor1	11498-119F4	96.67	0.94	1.13	0.00	0.19	0.19
Schwann Cells, donor2	11578-120F3	108.88	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	122.69	1.97	1.10	0.00	0.88	0.44
Sebocyte, donor1	11220-116B5	109.55	2.19	1.10	0.00	1.10	0.00
Sebocyte, donor2	11301-117B5	80.42	1.84	0.46	0.00	1.38	0.46
Sebocyte, donor3	11378-118B1	53.80	0.41	0.21	0.00	1.44	0.41
Sertoli Cells, donor1	11255-116F4	59.64	0.00	1.66	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	59.31	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	77.95	3.96	3.08	0.62	1.85	0.79
Skeletal Muscle Cells, donor2	11358-117H8	54.21	5.06	0.72	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	110.36	3.34	1.67	0.00	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	96.93	2.83	2.20	0.94	0.94	0.79
Skeletal Muscle Cells, donor5	11455-119A6	87.40	1.64	2.53	0.00	1.04	0.59
Skeletal Muscle Cells, donor6	11459-119B1	97.88	1.54	2.00	0.92	1.85	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	134.57	3.65	1.39	0.38	3.15	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	106.73	3.14	1.14	0.14	2.00	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	116.87	2.98	3.17	0.89	1.59	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	105.06	2.86	1.94	1.10	1.01	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	86.85	2.17	0.72	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	79.67	4.40	0.96	0.96	2.20	0.55
Skin - palm, donor1	10286-104F7	59.09	10.74	2.69	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	36.18	0.29	0.29	0.14	1.73	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	35.99	0.82	1.64	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	42.84	1.04	0.26	0.26	1.30	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	58.24	2.22	0.42	0.28	3.61	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	46.14	1.97	0.14	1.27	2.67	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	26.64	0.85	0.63	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	74.58	2.77	0.15	0.75	2.55	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	161.08	4.94	0.31	0.62	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	44.02	0.44	0.67	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	73.48	7.64	0.59	0.59	2.35	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	91.05	2.65	0.22	0.88	1.10	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	61.43	5.91	0.39	0.00	1.97	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	60.26	3.09	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	34.03	2.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	77.98	4.39	0.67	0.40	1.33	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	68.27	3.55	0.89	1.11	2.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	113.82	5.51	2.05	1.15	2.82	1.15
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	72.28	2.60	0.98	0.33	0.98	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	63.49	2.66	1.77	1.18	0.89	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	51.68	2.42	0.28	0.28	1.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	90.12	4.39	2.28	0.81	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	92.24	7.31	1.52	3.04	0.91	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	69.71	4.80	0.76	0.51	1.77	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	177.50	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	54.84	1.43	1.91	0.48	1.43	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	59.43	3.24	0.88	0.74	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	79.64	1.94	1.29	0.22	0.65	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	66.86	1.78	1.05	0.10	1.57	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	81.52	5.10	0.62	0.62	0.93	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	64.67	3.23	0.00	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	58.58	4.18	1.49	0.00	0.90	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	96.96	1.71	1.02	0.68	1.71	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	84.34	3.14	0.86	0.39	0.71	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	72.46	6.14	1.31	1.61	3.52	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	42.32	2.28	0.68	0.68	0.91	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	60.38	4.83	1.21	0.60	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	117.89	6.36	2.91	2.12	1.32	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	75.50	2.53	1.20	0.53	1.07	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	71.38	2.75	1.38	0.38	1.63	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	43.12	3.80	0.51	0.25	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	83.23	4.82	0.90	0.45	1.36	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	54.01	4.50	0.00	0.75	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	590.54	1.29	0.00	0.00	9.05	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	71.62	0.47	0.93	0.47	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	57.56	2.52	1.01	0.50	0.50	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	48.58	3.45	0.00	0.63	1.57	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	67.26	3.24	0.29	0.00	1.77	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	129.46	5.41	2.50	1.42	1.17	0.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	67.27	2.80	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	71.24	3.45	0.43	0.14	2.01	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	83.63	2.55	1.27	0.51	1.78	2.29
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	72.39	1.69	0.56	0.56	1.88	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	109.42	1.96	0.98	0.14	0.70	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	72.48	1.51	0.84	0.17	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	37.14	0.48	0.00	0.48	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	79.76	4.40	0.49	0.00	2.20	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	58.55	2.87	1.10	0.88	1.10	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	47.11	2.34	0.59	0.29	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	45.29	3.89	0.00	0.19	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	50.78	5.29	0.53	1.59	0.26	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	50.21	2.60	0.00	0.37	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	63.96	6.83	1.08	3.23	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	45.42	5.11	0.28	2.56	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	87.83	2.76	0.00	0.00	0.00	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	49.77	5.08	1.02	1.52	0.76	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	53.91	4.39	0.00	0.40	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	45.56	3.34	0.00	0.84	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	55.92	6.42	0.00	4.58	0.00	0.00
Synoviocyte, donor1	11291-117A4	50.83	2.02	1.01	0.84	1.51	0.17
Synoviocyte, donor2	11368-117I9	44.25	5.03	0.67	1.68	2.01	0.00
Synoviocyte, donor3	11440-118H9	44.68	4.24	0.45	1.12	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	137.93	1.79	2.50	0.00	0.36	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	63.43	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	82.89	1.16	1.85	0.46	0.69	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	72.33	1.79	0.29	0.22	1.58	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	36.72	1.55	0.00	0.00	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	47.53	1.15	1.15	0.00	1.15	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	51.67	2.34	0.12	0.49	0.74	0.00
Urethra, donor2	10319-105A4	30.57	3.60	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	61.63	0.53	0.53	0.00	1.06	0.27
Urothelial Cells, donor2	11600-120H7	57.68	0.80	0.80	0.00	3.20	0.00
Urothelial Cells, donor3	11681-122H7	41.72	0.23	0.00	0.00	0.46	0.00
Urothelial cells, donor0	11216-116B1	51.27	0.67	0.45	0.00	0.89	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	552.56	127.24	0.00	132.58	2.67	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	486.07	150.11	5.72	177.27	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	717.38	73.24	0.00	67.77	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	111.91	28.24	0.69	22.73	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	117.37	31.38	0.00	29.05	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	330.07	76.01	0.00	127.03	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	462.57	117.48	0.92	147.76	3.67	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	503.01	69.38	0.00	62.08	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	74.51	1.23	3.58	0.37	0.74	1.11
Wilms' tumor cell line:HFWT	10597-108E3	77.44	3.52	6.16	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	79.33	1.68	0.56	2.23	1.68	1.12
achilles tendon, donor2	10292-104G4	88.86	4.13	0.00	6.20	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	80.57	2.29	0.25	2.80	2.04	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	136.29	1.86	2.55	0.00	2.09	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	135.92	2.49	7.36	0.36	1.42	2.02
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	111.57	3.81	7.35	0.82	1.09	2.99
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	192.82	3.37	1.97	0.56	1.41	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	99.82	1.69	0.00	0.21	0.42	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	108.88	7.08	2.72	1.36	2.18	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	175.81	2.64	1.32	0.00	1.32	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	97.60	0.82	0.41	0.00	2.04	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	124.64	5.05	1.55	0.78	1.94	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	208.29	17.66	5.89	8.10	3.31	4.60
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	132.62	0.00	0.00	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	133.62	3.72	0.93	0.46	0.93	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	193.92	2.33	2.59	1.04	1.55	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	245.78	3.51	0.58	0.88	3.21	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	115.26	1.39	0.46	0.46	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	128.72	0.82	0.00	0.41	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	772.59	4.30	0.92	0.61	1.84	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	553.01	10.24	3.84	2.13	4.27	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	663.30	14.25	2.43	1.21	6.37	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	637.87	11.79	2.41	1.44	4.57	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	138.77	3.34	2.23	1.11	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	104.07	1.00	0.67	0.67	2.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	109.63	5.57	3.72	1.86	1.86	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	324.30	4.52	4.52	1.51	3.77	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	149.16	5.23	3.49	1.31	1.74	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	48.74	11.25	0.00	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	53.22	3.06	0.24	1.41	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	69.96	7.14	0.78	1.86	1.24	0.16
adipose, donor1	10184-103D4	96.17	0.59	1.76	0.00	9.38	0.00
adipose, donor2	10185-103D5	85.16	3.24	4.06	0.41	0.81	2.84
adipose, donor3	10186-103D6	80.33	2.72	3.27	0.54	3.27	0.54
adipose, donor4	10187-103D7	138.68	0.00	1.73	0.87	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	91.54	2.05	1.10	0.00	2.21	0.16
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	110.33	3.34	0.93	0.53	0.80	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	125.77	5.00	1.43	0.71	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	36.40	2.09	0.93	1.16	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	56.46	0.68	0.00	0.00	1.35	0.00
amniotic membrane cells, donor3	12237-129G5	38.89	1.77	0.00	1.47	0.29	0.00
amygdala - adult, donor10196	10167-103B5	11.86	1.19	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	23.93	1.22	0.61	0.00	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	28.73	5.16	2.26	3.23	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	57.30	1.78	0.76	0.00	1.27	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	102.15	4.41	2.43	0.66	2.43	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	90.19	3.34	4.34	0.67	1.34	0.00
aorta, adult, pool1	10052-101G7	44.91	2.94	0.00	0.59	0.78	0.20
appendix, adult	10189-103D9	72.97	6.60	1.55	2.72	2.33	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	87.36	5.85	7.22	2.06	0.34	2.41
artery, adult	10190-103E1	126.36	0.00	1.36	0.00	5.43	0.00
astrocytoma cell line:TM-31	10425-106D2	84.60	1.16	1.74	0.14	1.45	0.29
b cell line:RPMI1788	10427-106D4	125.06	6.84	1.34	0.74	1.49	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	63.81	3.88	0.55	0.55	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	75.12	3.57	1.09	0.79	1.89	1.29
bile duct carcinoma cell line:TFK-1	10496-107C1	19.75	1.67	0.33	1.34	0.67	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	83.89	2.24	0.00	0.56	2.24	0.00
bladder, adult, pool1	10011-101C2	56.06	6.95	1.52	0.43	1.96	0.22
blood, adult, pool1	10053-101G8	272.40	17.72	0.00	19.93	6.64	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	42.82	5.14	0.86	0.86	0.86	0.00
bone marrow, adult	10192-103E3	65.46	6.07	0.00	0.67	0.67	0.00
brain, adult, donor1	10084-102B3	11.28	1.03	2.05	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	20.60	1.56	1.34	0.22	0.22	0.22
brain, fetal, pool1	10085-102B4	120.21	8.01	13.36	0.00	0.00	8.01
breast carcinoma cell line:MCF7	10482-107A5	47.90	4.29	0.66	0.66	0.00	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	38.07	2.12	0.37	0.12	0.37	0.62
breast, adult, donor1	10080-102A8	43.56	4.42	0.00	0.00	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	82.57	9.53	3.30	4.95	0.64	2.67
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	107.92	3.40	1.86	0.62	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	166.45	0.23	0.46	0.00	1.84	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	91.51	3.15	1.69	0.97	1.94	0.73
carcinoid cell line:NCI-H1770	10703-109H1	150.45	0.94	5.64	0.94	0.94	1.41
carcinoid cell line:NCI-H727	10735-110B6	76.02	3.72	1.86	2.19	1.20	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	116.93	7.92	11.09	1.27	1.27	5.07
carcinosarcoma cell line:JHUCS-1	10642-109A3	181.27	5.59	9.05	1.33	1.60	1.86
caudate nucleus - adult, donor10196	10177-103C6	20.72	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	18.91	0.33	0.84	0.00	0.33	0.00
caudate nucleus, adult, donor10258	10379-105H1	14.52	0.76	0.76	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	49.81	2.56	3.30	0.73	0.73	0.73
cerebellum - adult, donor10196	10173-103C2	49.53	0.00	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	36.94	0.64	0.85	0.00	0.00	0.43
cerebellum, adult, pool1	10083-102B2	24.15	0.69	0.00	0.34	0.69	1.03
cerebellum, newborn, donor10223	10357-105E6	63.93	3.32	0.83	2.49	0.00	0.00
cerebral meninges, adult	10188-103D8	23.45	3.78	0.50	0.25	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	57.01	0.00	0.73	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	101.80	5.75	4.46	1.87	0.86	1.29
cervical cancer cell line:ME-180	10553-107I4	40.60	2.15	0.50	1.16	0.66	0.00
cervix, adult, pool1	10013-101C4	53.13	3.15	1.05	0.42	2.73	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	52.25	1.53	0.42	0.56	0.98	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	20.90	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	103.52	0.99	1.74	0.00	4.72	0.75
choriocarcinoma cell line:SCH	10785-110H2	47.44	0.74	0.62	0.00	1.36	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	89.89	3.32	0.24	1.19	1.90	0.00
chorionic membrane cells, donor1	12238-129G6	21.08	2.56	0.28	0.00	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	45.94	1.19	0.20	0.20	2.49	0.20
chorionic membrane cells, donor3	12240-129G8	48.35	4.40	0.00	0.55	1.10	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	135.31	5.05	6.06	1.01	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	97.59	3.27	1.73	0.38	1.34	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	141.49	9.29	2.53	4.86	2.11	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	176.94	15.15	12.33	6.42	1.03	4.37
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	187.46	7.50	11.13	2.90	1.69	4.60
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	184.27	11.40	6.92	4.48	2.24	4.48
chronic myelogenous leukemia cell line:K562	10454-106G4	79.21	8.54	11.19	4.71	0.88	4.12
chronic myelogenous leukemia cell line:KU812	10409-106B4	200.16	7.56	3.91	3.13	1.82	2.35
clear cell carcinoma cell line:JHOC-5	10638-108I8	156.12	5.03	1.37	0.46	2.06	1.60
clear cell carcinoma cell line:TEN	10636-108I6	67.67	1.74	0.35	0.52	0.17	0.35
colon carcinoma cell line:CACO-2	10513-107D9	46.86	1.28	1.83	0.37	0.55	0.92
colon carcinoma cell line:COLO-320	10420-106C6	114.40	1.52	15.20	1.14	0.76	2.66
colon, adult, donor1	10082-102B1	32.13	3.57	0.00	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	51.23	3.53	0.59	1.06	4.35	0.24
colon, fetal, donor1	10070-101I7	30.90	1.85	1.24	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	41.25	13.75	13.75	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	56.94	6.80	1.27	4.67	1.70	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	94.18	4.08	1.06	2.41	1.66	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	114.50	4.09	1.13	1.55	0.71	0.14
corpus callosum, adult, pool1	10042-101F6	45.99	2.10	2.21	0.33	0.44	0.44
cruciate ligament, donor2	10295-104G7	74.56	4.05	1.62	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	51.36	1.61	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	25.68	1.44	0.96	0.00	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	161.42	1.61	2.76	0.23	2.98	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	121.30	4.62	2.82	2.31	1.54	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	63.31	5.54	2.17	2.17	1.44	0.96
ductus deferens, adult	10196-103E7	32.89	1.99	1.00	0.50	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	24.48	5.76	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	54.44	2.94	1.47	2.21	2.21	0.74
dura mater, adult, donor1	10041-101F5	109.51	5.70	1.90	0.33	1.40	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	47.97	15.99	10.88	5.77	2.89	4.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	75.37	2.01	6.88	0.57	2.01	2.01
embryonic pancreas cell line:1B2C6	10604-108F1	48.10	7.40	2.47	1.85	0.00	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	65.39	6.36	5.45	0.00	1.51	2.72
embryonic pancreas cell line:1C3IKEI	10606-108F3	72.25	6.48	4.94	4.01	0.62	1.54
embryonic pancreas cell line:2C6	10603-108E9	68.30	5.25	1.31	0.00	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	54.97	3.02	5.36	0.67	0.00	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	88.62	9.24	3.26	0.54	1.27	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	63.84	2.57	0.16	0.32	1.93	0.48
epidermoid carcinoma cell line:A431	10426-106D3	97.60	4.11	0.89	2.67	2.11	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	115.70	1.32	2.53	1.21	1.21	0.77
epididymis, adult	10197-103E8	61.54	4.60	1.47	0.42	1.67	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	83.74	7.10	3.02	0.53	0.53	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	79.83	6.29	3.93	0.39	0.39	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	124.89	1.97	1.83	1.97	0.92	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	130.70	1.18	0.98	1.38	1.57	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	136.90	1.57	1.23	1.23	2.91	0.34
esophagus, adult, pool1	10015-101C6	61.37	2.65	0.64	0.11	2.12	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	71.63	18.53	9.77	2.63	0.88	1.13
eye - muscle inferior rectus, donor1	10272-104E2	72.44	4.83	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	75.75	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	40.18	2.98	1.49	4.46	0.00	1.49
eye - muscle superior, donor2	10297-104G9	57.32	5.73	0.00	1.15	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	67.04	0.00	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	84.15	3.31	1.53	0.51	2.03	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	60.01	1.92	0.90	0.51	0.51	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	99.48	6.65	3.09	1.42	1.90	1.90
frontal lobe, adult, pool1	10040-101F4	15.48	1.03	0.56	0.19	0.38	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	54.04	3.30	0.30	1.20	1.20	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	56.78	2.65	2.83	0.64	0.37	1.19
gall bladder, adult	10198-103E9	47.32	6.76	0.97	1.93	1.69	0.00
gamma delta positive T cells, donor1	11937-126A2	71.40	3.76	0.00	0.00	1.61	2.15
gamma delta positive T cells, donor2	11938-126A3	72.08	1.12	0.00	0.00	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	76.88	0.84	0.00	0.63	2.11	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	128.62	7.54	4.45	4.64	0.39	0.97
gastric cancer cell line:AZ521	10549-107H9	112.31	2.46	4.59	0.66	1.48	0.82
gastric cancer cell line:GSS	10560-108A2	75.05	3.66	3.66	0.00	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	42.95	2.51	2.06	2.06	1.83	1.14
giant cell carcinoma cell line:LU65	10487-107B1	65.63	7.11	5.28	14.00	0.34	1.03
giant cell carcinoma cell line:Lu99B	10433-106E1	84.12	3.92	2.80	0.98	0.84	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	63.10	3.49	0.25	0.25	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	42.64	1.06	1.06	0.21	0.00	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	36.23	1.12	1.12	0.42	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	119.76	2.65	1.88	0.44	0.88	0.44
glioma cell line:GI-1	10413-106B8	67.65	6.15	2.05	1.76	0.88	0.29
globus pallidus - adult, donor10196	10175-103C4	18.95	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	48.09	1.46	1.22	0.24	0.73	0.00
globus pallidus, adult, donor10258	10367-105F7	39.71	2.74	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	31.98	2.13	1.07	3.20	0.00	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	4.89	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	10.93	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	57.49	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	45.44	1.60	0.32	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	106.51	2.30	8.72	0.00	0.46	2.30
hIPS +CCl2, biol_rep2	14384-156C1	100.14	0.91	4.12	0.46	0.91	2.29
hIPS +CCl2, biol_rep3	14385-156C2	108.21	4.51	6.44	0.64	0.64	2.58
hIPS, biol_rep1	14380-156B6	125.04	0.00	4.31	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	117.97	2.06	6.17	1.37	0.00	1.37
hIPS, biol_rep3	14382-156B8	94.90	1.10	2.21	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	104.31	9.77	1.15	0.86	1.44	0.00
heart - mitral valve, adult	10205-103F7	63.98	2.39	0.90	0.60	0.90	0.60
heart - pulmonic valve, adult	10206-103F8	70.86	1.83	0.26	0.26	1.83	0.26
heart - tricuspid valve, adult	10207-103F9	114.90	6.66	2.50	2.50	3.33	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	55.50	1.63	0.20	0.00	1.02	0.00
heart, adult, diseased, donor1	10051-101G6	54.08	0.43	0.00	0.00	2.55	0.43
heart, adult, pool1	10016-101C7	81.64	1.84	0.46	0.46	1.84	0.46
heart, fetal, pool1	10046-101G1	122.91	2.57	0.82	0.82	1.54	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.32	0.93	0.00	0.00	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	59.46	1.19	4.76	0.00	1.19	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	88.40	1.55	4.31	0.44	1.88	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	91.52	1.34	5.70	0.73	2.31	1.34
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	95.90	1.41	5.76	0.40	1.21	1.21
hepatoma cell line:Li-7	10484-107A7	42.04	0.78	1.11	0.67	0.78	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	125.42	4.12	3.52	1.61	1.71	2.21
hippocampus - adult, donor10196	10169-103B7	19.87	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	25.10	0.82	0.20	0.00	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	22.91	1.00	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	40.18	4.58	2.82	1.41	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	89.72	2.44	4.88	0.00	3.05	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	74.42	1.77	3.73	0.79	3.14	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	89.63	2.29	8.38	0.51	4.32	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	113.34	1.13	1.69	0.00	7.33	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	106.90	1.29	3.36	0.00	2.58	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	117.30	1.52	4.18	0.00	5.69	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	105.69	4.09	8.76	0.58	3.21	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	96.94	2.37	7.54	0.86	1.72	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	120.53	3.34	7.51	0.42	1.25	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	115.32	2.13	3.79	0.24	1.89	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	99.16	1.61	5.46	0.64	3.05	2.41
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	90.90	2.69	5.39	0.00	2.02	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	74.17	0.94	7.20	0.78	3.44	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	94.33	1.47	5.90	0.00	1.97	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	85.53	3.49	5.24	0.00	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	100.04	0.76	2.67	0.19	4.20	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	101.17	0.87	0.87	0.00	2.18	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	90.96	0.50	2.50	0.00	4.50	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	75.17	3.58	3.96	1.13	1.51	2.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	85.49	1.82	7.73	1.82	1.82	3.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	81.13	4.39	5.01	1.25	0.63	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	68.10	1.31	4.57	0.16	2.45	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	72.58	2.03	2.90	0.00	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	80.11	1.49	0.60	0.00	0.90	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	67.99	0.92	6.28	0.00	2.22	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	66.19	0.57	5.71	0.86	2.28	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	93.50	1.63	6.94	0.41	5.31	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	95.06	0.70	1.76	0.00	3.52	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	89.32	1.58	2.22	0.00	3.17	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	88.06	1.82	2.42	0.30	1.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	75.50	1.03	3.62	0.00	1.03	3.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	83.68	2.66	1.33	0.66	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	79.01	4.36	1.28	0.51	1.03	3.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	80.27	2.30	1.79	0.26	1.02	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	90.11	0.00	4.54	0.00	0.00	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	75.95	2.02	1.34	0.00	0.34	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	74.38	1.45	7.00	0.00	3.14	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	78.88	1.34	4.90	0.45	2.23	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	86.34	0.98	8.29	0.49	4.88	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	112.16	1.22	1.22	0.31	0.92	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	348.10	6.51	3.25	0.00	32.53	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	114.18	0.33	2.32	0.00	6.95	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	105.08	3.83	4.38	0.55	2.74	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	97.71	2.17	3.62	0.72	2.17	1.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	97.15	2.49	3.91	0.00	0.36	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	87.12	2.39	3.58	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	110.10	1.35	3.39	0.14	2.98	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	87.01	0.54	2.16	0.00	1.08	1.35
immature langerhans cells, donor1	11904-125F5	117.93	6.54	0.00	4.60	0.24	0.24
immature langerhans cells, donor2	11905-125F6	72.88	3.96	0.79	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	16.37	2.37	1.32	0.00	0.19	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	45.20	1.30	0.33	0.33	1.95	0.00
kidney, adult, pool1	10017-101C8	55.67	3.10	0.50	0.50	1.00	0.20
kidney, fetal, pool1	10045-101F9	47.75	2.48	1.27	0.50	0.64	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	118.02	5.82	8.95	1.28	1.70	3.12
large cell lung carcinoma cell line:NCI-H460	10839-111E2	39.26	1.38	3.04	0.14	0.97	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	68.81	2.39	2.39	0.18	1.10	0.00
left atrium, adult, donor1	10079-102A7	52.85	0.54	0.54	0.00	1.09	0.00
left ventricle, adult, donor1	10078-102A6	62.70	0.51	0.00	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	91.66	1.92	4.10	0.00	0.82	1.64
leiomyoma cell line:10964C	10569-108B2	47.06	6.47	0.72	1.08	2.51	1.08
leiomyoma cell line:15242A	10570-108B3	33.15	4.35	0.00	1.09	1.63	0.54
leiomyoma cell line:15425	10571-108B4	45.16	6.56	0.97	0.49	2.19	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	6.35	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	63.78	4.18	0.00	0.00	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	237.18	19.48	6.97	9.33	3.54	3.07
liposarcoma cell line:KMLS-1	10782-110G8	52.02	3.44	1.25	0.94	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	42.28	0.97	1.46	0.12	0.85	0.37
liver, adult, pool1	10018-101C9	47.65	1.13	0.49	0.32	4.38	0.00
liver, fetal, pool1	10086-102B5	43.27	1.88	0.00	0.94	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	17.79	1.46	0.87	0.44	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	24.73	0.55	0.00	0.18	0.18	0.00
locus coeruleus, adult, donor10258	10375-105G6	11.00	1.97	0.56	0.00	0.28	0.56
locus coeruleus, newborn, donor10223	10362-105F2	41.22	2.52	0.00	1.68	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	38.61	3.60	1.80	0.14	0.14	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	54.46	6.20	2.07	2.76	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	75.66	13.58	8.44	1.32	0.66	3.30
lung, adult, pool1	10019-101D1	68.99	5.55	0.24	0.59	2.13	0.12
lung, fetal, donor1	10068-101I5	84.77	9.70	0.86	4.00	0.29	0.57
lung, right lower lobe, adult, donor1	10075-102A3	39.41	2.75	0.00	1.37	0.00	0.00
lymph node, adult, donor1	10077-102A5	67.22	3.79	0.95	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	64.22	1.53	1.10	0.66	0.88	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	110.78	11.77	4.38	2.11	0.75	1.81
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	50.97	9.34	3.40	4.25	0.85	1.70
mature adipocyte, donor1	12231-129F8	56.39	7.10	0.44	1.33	0.89	0.00
mature adipocyte, donor2	12232-129F9	55.20	7.26	0.21	0.62	0.83	0.42
mature adipocyte, donor3	12233-129G1	58.55	4.03	0.71	0.47	0.47	0.24
mature adipocyte, donor4	12234-129G2	62.12	4.74	0.79	0.00	1.05	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	144.86	21.44	11.44	8.10	3.34	3.57
medial frontal gyrus - adult, donor10196	10170-103B8	14.66	0.00	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	24.64	0.18	0.37	0.00	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	12.71	0.32	0.00	0.32	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	52.03	5.12	2.56	5.12	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	12.83	1.18	0.17	0.00	0.34	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	23.98	0.00	1.27	0.00	0.42	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	51.33	6.10	1.08	3.59	1.08	0.72
medulla oblongata - adult, donor10196	10174-103C3	18.17	1.95	1.30	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	35.76	1.24	0.46	0.00	0.31	0.15
medulla oblongata, adult, pool1	10038-101F2	28.16	2.37	1.47	0.57	0.00	0.41
medulla oblongata, newborn, donor10223	10361-105F1	27.43	2.78	1.74	0.00	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	245.77	0.89	11.29	0.00	1.11	2.66
medulloblastoma cell line:ONS-76	10759-110E3	81.80	2.45	4.40	0.12	0.73	1.35
melanoma cell line:COLO 679	10514-107E1	56.92	2.01	0.57	1.01	2.01	0.14
melanoma cell line:G-361	10465-106H6	73.84	4.07	0.54	1.63	3.53	0.00
meningioma cell line:HKBMM	10691-109F7	32.56	2.35	0.72	0.54	0.90	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	129.53	1.76	3.52	0.00	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	159.94	2.33	6.48	0.26	2.33	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	113.23	3.84	1.69	0.61	2.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	75.44	2.00	0.55	0.73	1.27	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	127.54	4.14	0.41	0.83	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	78.39	5.76	0.42	1.40	0.84	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	55.46	6.35	0.58	0.39	0.58	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	53.44	6.25	0.00	3.47	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	48.40	4.63	0.34	0.69	1.03	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	61.42	3.68	0.35	0.58	1.15	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	90.59	2.65	0.40	0.53	1.19	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	77.92	3.51	0.54	1.35	0.68	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	79.52	2.56	0.43	0.28	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	52.37	3.29	0.99	0.33	1.65	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	67.39	1.25	0.42	0.14	0.83	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	85.53	3.49	0.70	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	59.41	2.45	0.20	0.20	1.43	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	53.56	1.08	0.36	0.00	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	46.86	1.14	0.31	0.21	0.41	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	42.18	0.46	0.46	0.23	0.00	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	108.67	2.52	1.26	2.52	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	80.40	3.14	0.30	0.30	0.45	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	68.45	0.96	0.09	0.53	0.35	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	63.69	3.31	0.00	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	63.81	2.29	0.57	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	102.73	0.42	0.84	1.26	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	59.82	4.57	0.46	0.91	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	70.85	3.84	0.26	1.53	1.53	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	79.05	4.19	0.26	0.79	0.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	76.10	4.01	0.62	0.62	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	69.67	4.24	0.47	0.47	0.71	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	69.72	3.05	0.68	0.00	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	76.24	3.14	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	68.58	3.71	0.93	0.46	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	83.06	4.90	1.73	0.58	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	70.72	3.12	0.45	1.56	1.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	70.66	5.77	0.24	1.44	0.96	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	73.33	3.67	1.47	1.47	0.73	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	68.81	3.69	1.34	0.67	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	71.23	4.91	0.41	0.41	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	73.02	1.29	0.43	0.43	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	84.77	5.47	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	5.16	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	76.97	2.60	0.65	1.30	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	59.65	4.36	1.45	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	81.03	5.86	0.53	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	53.16	6.54	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	68.80	4.66	0.00	0.78	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	52.47	4.20	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	65.57	4.97	0.00	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	64.04	1.78	0.59	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	60.92	2.44	1.22	0.00	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	70.94	3.17	0.00	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	63.46	4.14	0.69	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	53.73	4.30	2.15	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	71.85	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	30.56	3.67	0.00	1.22	1.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	38.13	2.38	1.59	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	31.83	2.95	1.18	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	30.24	4.99	0.62	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	22.72	6.68	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	41.39	2.37	1.18	0.00	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	46.22	0.00	2.57	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	60.58	2.75	0.69	1.38	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	55.91	1.48	1.48	0.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	43.74	5.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	64.88	1.91	0.64	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	73.34	0.81	0.40	0.40	1.61	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	56.70	0.00	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	72.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	59.47	3.03	0.61	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	9.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	55.19	2.47	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	31.15	2.38	0.40	0.79	0.40	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	37.97	1.62	0.00	0.97	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	41.76	2.04	1.02	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	18.57	3.09	0.00	0.77	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	80.09	8.03	2.60	0.47	0.47	1.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	52.36	4.63	2.09	1.62	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	64.10	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	39.87	1.44	0.31	0.21	1.64	0.31
mesothelioma cell line:Mero-25	10850-111F4	59.01	0.68	1.59	0.23	1.36	0.45
mesothelioma cell line:Mero-41	10851-111F5	147.42	0.49	0.98	0.00	1.96	0.00
mesothelioma cell line:Mero-48a	10852-111F6	135.96	3.54	0.22	0.44	1.55	0.22
mesothelioma cell line:Mero-82	10853-111F7	78.05	1.84	1.84	1.05	2.37	0.26
mesothelioma cell line:Mero-83	10854-111F8	85.79	2.72	1.70	0.68	2.55	0.51
mesothelioma cell line:Mero-84	10855-111F9	33.87	0.25	0.00	0.00	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	64.80	2.48	0.62	0.21	2.28	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	71.89	1.99	1.49	0.00	0.83	0.33
mesothelioma cell line:NCI-H226	10846-111E9	98.64	4.16	1.81	0.90	1.45	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	121.97	3.93	1.37	1.02	1.88	0.51
mesothelioma cell line:NCI-H28	10845-111E8	121.38	4.07	4.07	0.76	1.27	0.51
mesothelioma cell line:No36	10857-111G2	48.60	0.00	0.00	0.00	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	69.09	2.71	1.35	0.54	1.08	0.00
migratory langerhans cells, donor1	11901-125F2	74.66	0.96	0.00	0.38	0.77	0.00
migratory langerhans cells, donor2	11902-125F3	49.58	0.98	0.12	0.00	0.49	0.00
migratory langerhans cells, donor3	11903-125F4	59.59	0.90	0.18	0.00	0.72	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	55.83	0.33	0.33	0.00	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	63.58	0.42	1.27	0.21	1.06	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	41.23	3.23	0.46	2.76	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	63.37	1.71	0.38	0.00	1.33	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	113.09	1.85	1.48	0.18	1.66	0.55
myeloma cell line:PCM6	10474-106I6	47.04	2.37	0.59	2.57	0.79	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	29.93	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	156.13	4.12	1.18	0.98	1.18	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	53.60	1.34	0.22	0.33	0.45	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	48.02	3.02	0.22	0.96	0.59	0.37
nasal epithelial cells, donor2	12227-129F4	115.92	1.66	1.10	1.10	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	61.20	4.37	22.55	0.46	1.15	11.96
neuroblastoma cell line:NB-1	10539-107G8	65.67	0.56	0.56	0.19	0.75	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	239.57	4.01	25.31	2.32	3.16	3.37
neuroblastoma cell line:NH-12	10555-107I6	155.60	4.85	20.13	0.75	2.80	6.52
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	87.77	1.19	4.51	0.00	0.95	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	69.21	0.79	2.69	0.16	2.53	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	86.54	0.60	5.84	0.40	1.61	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	82.65	5.72	8.26	0.64	1.27	4.45
neurofibroma cell line:Hs 53.T	10729-110A9	43.65	2.13	0.80	0.53	0.53	1.06
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	196.18	1.01	1.86	0.68	1.86	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	58.44	1.60	1.60	0.00	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	40.08	4.17	0.00	1.28	1.60	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	42.57	3.42	0.79	1.05	0.53	0.00
nucleus accumbens, adult, pool1	10037-101F1	18.00	1.41	0.75	0.19	0.19	0.37
occipital cortex - adult, donor10196	10172-103C1	10.30	2.06	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	34.35	0.81	0.54	0.00	0.54	0.00
occipital cortex, newborn, donor10223	10355-105E4	55.68	4.73	1.82	1.46	0.00	0.73
occipital lobe, adult, donor1	10076-102A4	21.78	0.79	0.52	0.00	0.79	0.00
occipital lobe, fetal, donor1	10073-102A1	177.22	14.16	16.73	0.86	4.29	6.44
occipital pole, adult, pool1	10036-101E9	17.58	1.34	0.39	0.00	0.08	0.24
olfactory region, adult	10195-103E6	18.34	1.53	0.76	0.19	0.57	0.19
optic nerve, donor1	10277-104E7	38.02	4.00	2.00	0.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.88	4.67	2.16	3.53	1.25	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	107.99	12.36	10.85	3.85	0.96	3.43
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	62.31	5.76	1.52	2.03	1.52	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	152.59	1.96	1.50	0.69	1.85	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	62.61	0.29	0.29	0.00	2.65	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	76.62	6.54	3.74	0.00	0.00	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	79.73	1.48	3.18	1.48	1.48	0.64
ovary, adult, pool1	10020-101D2	41.93	4.80	3.41	0.52	1.83	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	68.38	1.47	1.10	0.00	1.65	0.00
pancreas, adult, donor1	10049-101G4	46.09	11.29	2.82	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	38.02	0.84	0.84	0.84	0.84	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	48.55	3.41	1.02	0.51	0.85	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	26.16	4.97	0.83	1.16	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	17.21	1.10	1.37	0.27	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	63.12	0.00	0.00	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	10.35	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	19.38	1.14	0.57	0.00	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	14.10	1.32	0.53	0.09	0.09	0.26
parietal lobe, fetal, donor1	10072-101I9	168.75	10.67	12.61	1.94	1.94	3.88
parietal lobe, newborn, donor10223	10356-105E5	57.57	4.86	1.50	4.49	0.75	0.37
parotid gland, adult	10199-103F1	54.27	3.70	0.00	1.85	0.00	0.00
penis, adult	10200-103F2	73.05	2.69	1.07	0.54	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	55.04	5.21	9.67	1.49	1.30	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	33.07	1.89	0.29	0.73	0.44	0.73
pineal gland - adult, donor10196	10179-103C8	51.60	3.87	1.29	0.65	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	44.42	4.74	0.59	1.18	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	30.10	5.64	3.14	1.25	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	25.30	1.01	0.00	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	26.58	5.73	3.13	1.04	0.52	1.04
pituitary gland, adult, donor10258	10378-105G9	20.43	5.11	0.00	1.70	0.85	0.85
placenta, adult, pool1	10021-101D3	39.02	2.69	0.32	0.54	0.32	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	121.44	3.44	2.91	1.06	1.06	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	45.76	2.18	0.47	0.16	1.25	0.16
pons, adult, pool1	10033-101E6	18.59	1.98	0.60	0.09	0.17	0.17
postcentral gyrus, adult, pool1	10032-101E5	17.70	1.13	0.78	0.26	0.09	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	52.28	8.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	99.14	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	63.36	2.04	1.02	0.29	0.73	0.29
prostate cancer cell line:PC-3	10439-106E7	83.85	1.82	2.72	0.54	2.00	1.09
prostate, adult, pool1	10022-101D4	50.52	5.08	1.36	0.45	1.90	0.09
putamen, adult, donor10196	10176-103C5	18.89	1.42	0.94	0.24	0.47	0.24
putamen, adult, donor10252	10152-102I8	13.73	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	53.55	2.19	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	21.26	2.66	0.72	0.24	0.24	0.00
putamen, newborn, donor10223	10365-105F5	55.47	1.50	3.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	26.18	8.73	0.58	8.15	0.87	1.16
rectum, fetal, donor1	10067-101I4	57.03	6.95	0.00	5.56	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	76.96	0.64	1.06	0.21	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	50.12	5.80	3.73	0.00	0.41	1.24
retina, adult, pool1	10030-101E3	64.81	3.58	1.49	0.70	0.89	0.10
retinoblastoma cell line:Y79	10475-106I7	202.91	1.04	12.21	0.26	0.78	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	63.69	0.61	1.72	0.12	1.48	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	177.44	5.62	24.18	0.28	0.84	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	40.17	0.76	0.76	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	80.28	4.69	1.13	1.46	1.78	0.16
salivary acinar cells, donor2	11772-123I8	114.42	5.09	0.69	2.62	2.89	0.00
salivary acinar cells, donor3	11773-123I9	40.39	4.63	0.00	5.30	0.00	0.00
salivary gland, adult, pool1	10093-102C3	44.61	4.58	0.57	1.14	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	82.96	12.39	1.43	3.04	1.35	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	65.48	10.93	1.29	1.41	0.71	0.47
seminal vesicle, adult	10201-103F3	36.51	4.23	0.53	0.53	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	61.70	3.16	0.73	1.21	1.21	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	100.65	1.26	0.50	1.51	1.01	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	127.45	0.00	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.34	1.07	0.27	0.13	0.54	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	71.84	8.29	1.88	6.52	1.11	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	57.03	8.00	0.65	3.23	0.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	81.57	2.84	2.84	0.00	2.13	2.84
skeletal muscle, adult, pool1	10023-101D5	156.28	5.40	4.20	0.24	6.24	1.44
skeletal muscle, fetal, donor1	10066-101I3	64.32	3.02	2.01	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	61.07	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	86.48	2.52	0.00	2.52	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	108.39	2.33	3.00	0.67	2.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	74.07	0.32	2.21	0.32	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	232.84	4.43	7.90	0.00	2.31	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	146.86	6.10	7.75	4.78	1.15	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	327.97	1.13	17.05	0.32	2.73	3.06
small cell lung carcinoma cell line:WA-hT	10562-108A4	165.40	1.96	2.18	0.44	1.74	0.65
small intestine, adult, pool1	10024-101D6	56.02	1.43	0.48	0.96	1.19	0.24
small intestine, fetal, donor1	10064-101I1	41.28	2.70	1.47	1.47	1.23	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	52.83	9.75	0.51	6.15	0.51	1.54
smooth muscle, adult, pool1	10048-101G3	71.08	5.94	1.29	0.26	1.81	0.26
somatostatinoma cell line:QGP-1	10781-110G7	74.24	23.05	2.68	6.97	0.54	2.41
spinal cord - adult, donor10196	10181-103D1	19.73	2.06	0.69	0.00	0.69	0.00
spinal cord, adult, donor10252	10159-103A6	29.96	2.37	0.39	0.39	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	38.74	2.08	0.69	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	54.89	2.44	3.66	1.83	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	41.33	2.30	0.46	0.92	1.84	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	46.00	2.09	0.60	0.60	0.15	0.00
spleen, adult, pool1	10025-101D7	78.20	4.41	0.66	0.66	1.54	0.00
spleen, fetal, pool1	10044-101F8	68.81	3.18	0.32	2.22	0.64	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	74.74	2.28	0.62	1.24	0.52	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	19.18	1.71	2.09	0.95	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	72.69	1.40	0.00	0.35	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	49.26	18.37	3.13	8.99	1.95	2.74
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	44.80	13.28	3.04	10.58	0.56	2.59
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	60.15	3.39	2.97	0.42	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	81.23	1.27	0.85	0.00	0.85	0.42
stomach, fetal, donor1	10062-101H8	37.38	9.61	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	45.00	2.28	0.00	0.57	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	31.99	1.87	1.04	0.21	0.62	0.21
substantia nigra, adult, donor10258	10371-105G2	37.24	1.03	1.55	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	28.97	3.53	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	78.87	1.15	6.65	0.00	2.75	1.83
temporal lobe, adult, pool1	10031-101E4	17.04	1.53	0.68	0.25	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	185.90	18.52	13.53	2.14	4.99	7.12
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	236.47	14.07	18.02	0.88	4.83	7.03
tenocyte, donor1	11763-123H8	92.51	3.49	0.70	0.35	1.05	0.00
tenocyte, donor2	11765-123I1	52.27	6.10	1.14	0.76	0.00	0.38
tenocyte, donor3	11768-123I4	95.63	4.08	1.11	1.11	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	184.07	2.89	14.11	1.87	2.21	3.06
teratocarcinoma cell line:NCR-G1	10798-110I6	30.98	0.00	0.31	0.00	0.77	0.15
teratocarcinoma cell line:PA-1	10807-111A6	77.02	0.62	1.39	0.15	1.86	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	108.54	4.95	2.79	0.63	3.55	0.76
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	166.77	3.03	3.40	0.38	0.76	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	105.68	9.49	1.64	1.74	2.62	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	91.52	3.26	2.93	0.65	2.61	1.30
testis, adult, pool1	10026-101D8	465.67	4.83	4.08	1.18	15.35	8.16
testis, adult, pool2	10096-102C6	1218.38	8.57	7.67	2.26	8.12	13.98
thalamus - adult, donor10196	10168-103B6	25.39	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	32.98	1.09	0.47	0.00	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.52	1.32	0.49	0.16	0.33	0.16
thalamus, newborn, donor10223	10366-105F6	42.00	4.60	2.30	1.15	0.58	0.00
throat, adult	10209-103G2	85.89	2.75	0.50	0.50	2.50	0.50
throat, fetal, donor1	10061-101H7	45.10	4.88	1.22	1.22	0.91	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	116.06	6.16	10.33	1.19	0.79	3.97
thymus, adult, pool1	10027-101D9	99.41	2.19	1.49	0.10	3.28	0.30
thymus, fetal, pool1	10043-101F7	64.42	1.87	0.83	0.52	1.56	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	57.31	1.46	0.80	0.40	0.66	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	63.56	2.10	0.98	0.98	1.54	0.42
thyroid, adult, pool1	10028-101E1	54.77	4.29	1.77	0.75	2.43	0.28
thyroid, fetal, donor1	10060-101H6	35.59	3.16	0.53	0.00	1.05	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	76.99	9.24	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	100.01	2.33	0.70	0.70	3.02	0.00
tongue, fetal, donor1	10059-101H5	61.87	1.18	0.79	0.39	2.36	0.00
tonsil, adult, pool1	10047-101G2	76.63	4.01	0.70	0.90	0.80	0.20
trachea, adult, pool1	10029-101E2	60.04	5.24	1.06	0.65	0.82	0.16
trachea, fetal, donor1	10058-101H4	44.24	1.15	1.15	1.15	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	58.81	4.61	0.35	0.35	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	92.50	3.75	2.74	1.82	1.62	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	138.98	4.54	2.98	1.88	2.51	0.63
tridermal teratoma cell line:HGRT	10694-109G1	49.47	9.51	0.00	0.00	1.90	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	62.73	6.86	1.44	2.54	1.19	1.02
umbilical cord, fetal, donor1	10057-101H3	45.90	4.17	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	61.94	6.31	2.05	0.34	0.51	0.00
uterus, fetal, donor1	10055-101H1	67.06	2.56	1.02	0.00	2.05	0.00
vagina, adult	10204-103F6	61.39	3.88	0.00	0.00	0.65	0.00
vein, adult	10191-103E2	53.27	4.38	0.44	0.44	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	84.38	3.47	1.07	0.27	0.80	0.53

Property "Nearest transcripts" (as page type) with input value "L28809:-10 M24070:-40 BC002411:-40 BC010430:-42 BC000064:-47 BC038384:-49 BC072014:-52 BC065571:-52 BC071708:-52 BC090038:-52 BC106045:-54 J03827:-54 ENST00000332220.10:-55 Z70765:-55 BC098435:-58 BC070084:-65 DQ894802:67 DQ891609:67 AK311708:-68 AK309996:-68 M83234:-68 M85234:-68 AB385072:68 ENST00000321358.12:-77 NM_004559.5:-77 LF356427:-86 MA592004:-86 ENST00000436427.1:491 BC013838:491" contains invalid characters or is incomplete and therefore can cause unexpected results during a query or annotation process.